Zepp Health (NYSE:ZEPP) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen lowered shares of Zepp Health (NYSE:ZEPP) from a hold rating to a sell rating in a research note published on Sunday.

Separately, Fundamental Research set a $53.01 target price on shares of Zepp Health and gave the stock a “buy” rating in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $53.01.

Zepp Health Stock Performance

Shares of ZEPP stock opened at $5.20 on Friday. The company has a quick ratio of 0.67, a current ratio of 0.88 and a debt-to-equity ratio of 0.21. The company has a 50 day moving average price of $5.05 and a 200-day moving average price of $11.28. Zepp Health has a 52 week low of $3.85 and a 52 week high of $61.85. The firm has a market capitalization of $76.34 million, a PE ratio of -2.06 and a beta of 1.86.

Insider Transactions at Zepp Health

In other Zepp Health news, CFO Cheng Deng sold 9,836 shares of the firm’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $4.61, for a total value of $45,343.96. Following the transaction, the chief financial officer directly owned 114,539 shares of the company’s stock, valued at approximately $528,024.79. This trade represents a 7.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 36.00% of the company’s stock.

Institutional Investors Weigh In On Zepp Health

Several hedge funds and other institutional investors have recently made changes to their positions in ZEPP. Monolith Management Ltd bought a new stake in Zepp Health during the fourth quarter valued at approximately $3,601,000. Harvest Fund Management Co. Ltd increased its holdings in Zepp Health by 6.7% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock valued at $1,207,000 after buying an additional 2,800 shares during the last quarter. Themes Management Co LLC bought a new position in Zepp Health in the fourth quarter worth approximately $489,000. Capstone Capital Management Ltd bought a new position in Zepp Health in the fourth quarter worth approximately $298,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of Zepp Health during the 4th quarter worth $543,000. Hedge funds and other institutional investors own 52.61% of the company’s stock.

Zepp Health Company Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.